EMRIS Pharma is developing a first-in-class topical drug to prevent skin toxicities caused by EGFR inhibitor antibodies in cancer patients.
| Website | http://www.emris-pharma.com |
| Employees | 7 (1 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Skin Cancer Treatment, Oncology Therapeutics, Cancer Supportive Care, Targeted Therapy, Pharmaceutical Research, Drug Development, Biotechnology, Clinical Trials, Molecular Medicine, Innovative Therapies, Skin Health, Medical Research, Pharmaceutical, Healthcare |
Looking for a particular EMRIS Pharma employee's phone or email?
Lyora Aharonov is the CEO and Co-founder of EMRIS Pharma.
1 people are employed at EMRIS Pharma.
EMRIS Pharma is based in Nazareth, North District.